Inflammatory responses of a human keratinocyte cell line to 10 nm citrate- and PEG-coated silver nanoparticles by Bastos, V. et al.
1 
 
Inflammatory responses of a human keratinocyte cell line to 10 nm 1 
citrate- and PEG-coated silver nanoparticles  2 
Bastos V.1, Brown D.2, Johnston H. 2, Daniel-da-Silva, A.L. 3, Duarte I.F. 3, Santos C. 1,4 and 3 
Oliveira H.1  4 
 5 
1CESAM & Laboratory of Biotechnology and Cytomics, University of Aveiro, 3810-193 Aveiro, Portugal 6 
2School of Life sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, UK 7 
3CICECO – Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal  8 
4Department of Biology & Greenup / Citab -UP, Faculty of Sciences, University of Porto, Rua do Campo Alegre, Porto 9 
 10 
*corresponding author: csantos@fc.up.pt 11 




Silver nanoparticles (AgNPs) are among the most commonly used engineered NPs and various 14 
commercially available products are designed to come in direct contact with the skin (wound 15 
dressings, textiles, creams, among others). Currently, there is limited understanding of the 16 
influence of coatings on the toxicity of AgNPs and in particular their ability to impact on AgNP’s 17 
mediated inflammatory responses. As AgNPs are often stabilized by different coatings, including 18 
citrate and polyethyleneglycol (PEG), in this study we investigate the influence of citrate (Cit10) 19 
or PEG (PEG10) coatings to 10 nm AgNP on skin, using human HaCaT keratinocytes. AgNPs 20 
cytotoxicity and inflammatory response (nuclear factor (NF)-κB induction and cytokine 21 
production) of HaCaT were assessed after in vitro exposure to 10 µg/mL and 40 µg/mL after 4, 22 
24 and 48 h. Results showed that although both types of coated AgNPs decreased cell proliferation 23 
and viability, Cit10 AgNPs were more toxic. NF-κB inhibition was observed for the highest 24 
concentration (40 µg/mL) of PEG10 AgNPs, and the putative link to early apoptotic pathways 25 
observed in these cells is discussed. No production of IL-1β, IL-6, IL-10 and TNFα was stimulated 26 
by AgNPs. Furthermore, Cit10 and PEG10 AgNPs decreased the release of MCP-1 by HaCaT 27 
cells after 48 h of exposure. As cytokines are vital for the immunologic regulation in the human 28 
body, and it is demonstrated that they may interfere with NPs, more research is needed to 29 
understand how different AgNPs affect the immune system. 30 
 31 
Introduction 32 
Nanotechnology-based consumer products are exponentially increasing, being nanosilver-33 
containing products among the most commonly used (Vance et al., 2015). Silver nanoparticles 34 
(AgNPs) are widely used due to their enhanced physicochemical properties and biological 35 
activities such as their antimicrobial activity. Their applications range from medicine and industry 36 
to household and personal care products (EPA, 2010) or clothing (Abdelhalim and Jarrar, 2011; 37 
Behra et al., 2013; Benn and Westerhoff, 2008; Eckhardt et al., 2013; Nowack et al., 2011). The 38 
increased exploitation of AgNPs and consequent release into the environment raises concerns 39 
about their possible impacts on the environment and on human health (Nowack and Bucheli, 40 
2007). There is an array of AgNPs that are being exploited, which vary with respect to their 41 
physicochemical properties (e.g. size, shape, charge, surface coating, dispersion state) (Ahlberg 42 
et al., 2014; Boonkaew et al., 2014; Comfort et al., 2014; Kim et al., 2012; Park et al., 2011b). 43 
Existing studies have demonstrated that the physicochemical properties of AgNPs are able to 44 
influence their toxicity for different cell lines [eg., human keratinocytes (HaCaT and primary 45 
keratinocytes), normal fibroblasts (NHF), rat adrenal pheochromocytoma (PC12), and mouse 46 
osteoblasts (MC3T3-E1), fibroblasts (L929) and macrophages (RAW 264.7)]. However, little 47 
attention has been given to the coating-dependent toxicity of AgNPs. Thus, research on the 48 
3 
 
toxicity of AgNPs of varied physicochemical properties is critical in order to better predict the 49 
risks they pose. 50 
It has been reported that nanoparticle coating, media composition and ionic strength influence the 51 
surface chemistry, shape, aggregation state and dissolution of AgNPs, which in turn can 52 
differently affect their cellular uptake and biological effects (Tejamaya et al., 2012). Indeed, a 53 
few studies addressing the uptake (by embryonic fibroblasts NIH/3T3, keratinocytes HaCaT and 54 
hepatoma cells Hepa-1c1c7, respectively) of different coated AgNPs and their influence on 55 
cytotoxicity have been reported (Caballero-Díaz et al., 2013; Lu et al., 2010; Pang et al., 2015). 56 
Citrate is the most commonly used reducing and stabilizing agent of AgNPs, rendering NPs with 57 
a negative surface charge and providing colloidal stability through electrostatic repulsions 58 
(Sharma et al., 2009). Among other coating agents of AgNPs, low molecular weight 59 
polyethyleneglycol (PEG), which stabilizes AgNPs through steric interactions, has been 60 
increasingly used in biomedical applications as it enhances biocompatibility and increases blood 61 
circulation time (Ginn et al., 2014; Ryan et al., 2008). 62 
Assessment of the ability of NPs to induce inflammatory responses is commonly used as an 63 
indicator of toxicity. For example, Chalew and Schwab (2013) studied the inflammatory effects 64 
of AgNPs, titanium dioxide (TiO2NPs), and zinc oxide (ZnONPs) (0, 0.1, 1, 10, and 100 mg/L) 65 
on human intestinal Caco-2 and SW480 cells and found that all NPs increased IL-8 cytokine 66 
generation in both cell lines. Also, Park et al (2011a) observed that pro-inflammatory cytokines 67 
(IL-1, TNF-α, and IL-6) and Th0 cytokine (IL-2) were progressively increased by day 28 after a 68 
single intratracheal instillation of AgNPs  in mice. Suliman and co-workers (2013b) found that 69 
50 µg/mL AgNPs exposure to human lung epithelial (A549) cells significantly increased the level 70 
of pro-inflammatory cytokines, namely interleukin-1β (IL-1β) and interleukin-6 (IL-6). Yang and 71 
collaborators also observed IL-1β release by human blood monocytes in response to AgNPs 72 
(Yang et al., 2012). However, Wong et al (2009) found an anti-inflammatory effect of AgNPs to 73 
two mouse macrophage cell lines, RAW264.7 and J774.1, where AgNPs blocked TNF-α 74 
production. On the other hand, we could not found studies reporting the induction of anti-75 
inflammatory cytokines after exposure to NPs (Murray et al., 2013; Orlowski et al., 2013; 76 
Samberg et al., 2009). Cytokines can strongly activate inflammatory responses and cell death in 77 
various tissues, including the skin (Fujiwara and Kobayashi, 2005; Graves et al., 2004). Indeed, 78 
a study on the effects of UVB radiation using HaCaT cells reported an increase of various pro-79 
inflammatory cytokines - interleukin (IL)-1β IL-6, IL-8, interferon (IFN)-γ, granulocyte-colony 80 
stimulating factor (G-CSF), macrophage inflammatory protein (MIP)-1β, and tumor necrosis 81 
factor (TNF)-α (Yoshizumi et al., 2008). Murray et al (2013) found increased IL-8 and IL-6 in 82 
human epidermal keratinocytes (HEK cells) after exposure to superparamagnetic iron oxide 83 
(SPION) NPs (2.6, 5.2, 13, and 26 µg/cm2 for 24 h). In other study using HEK cells, quantum dot 84 
NPs significantly increase IL-6 at 1.25 nM to 10 nM, while IL-8 increased from 2.5 nM to 10nM 85 
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after 24 h and 48 h (Zhang et al., 2008). Therefore, as products containing AgNPs can be applied 86 
to the skin (e.g. wound dressing), and as there are experimental evidences for skin penetration of 87 
25 ± 7 nm AgNPs (also in intact skin) (Larese et al., 2009) and 20 – 40 nm AgNPs (George et al., 88 
2014), the human keratinocyte cell line HaCaT was selected as an in vitro model in this study. It 89 
is well known that cytokines play crucial roles in immunologic regulation in the human body and 90 
are involved in the induction of proliferation, differentiation, and cell death in many cell types 91 
(Yarilin and Belyakov, 2004). Moreover, activation of the transcription factor nuclear factor 92 
kappa B (NF-κB) has been shown to play a central role in the enhanced expression and regulation 93 
of cytokine genes (Kelso, 1998). There is also evidence that carbon NPs can activate NF-κB in 94 
macrophages which stimulates TNFα production (Brown et al., 2004). To our knowledge, the 95 
activation of NF-κB in keratinocytes has not been studied previously. 96 
In our previous study (Bastos et al., 2016) we evaluated the toxicity of 30 nm AgNPs coated with 97 
citrate or PEG on HaCaT cells. Our results showed that Cit30 AgNPs were more cytotoxic than 98 
PEG30 AgNPs. Concerning cytokine release, both Cit30 and PEG30 AgNPs induced a decrease 99 
in MCP-1 production but no effect on other cytokines, namely IL-1β, IL-6, IL-10 and TNF-α 100 
(Bastos et al, 2016).  101 
In this study, we aimed to compare the inflammatory responses of HaCaT cells exposed to well-102 
characterized 10 nm AgNPs coated with citrate or PEG, in order to explore the influence of 103 
smaller sizes of AgNPs on the inflammatory response. In particular, the effects on viability, 104 
expression of the pro-inflammatory transcription factor NF-κB and production of cytokines such 105 
as interleukin-1 beta (IL-1β), IL-6, tumour necrosis factor-alpha (TNF-α), IL-10 and monocyte 106 
chemoattractant protein-1 (MCP-1) were assessed. 107 
 108 
Material and methods 109 
Chemicals 110 
Sterile, purified and endotoxin-free silver nanoparticles (Biopure AgNPs 1.0 mg/mL in water), 111 
with a diameter of 10 nm and a citrate or polyethyleneglycol (PEG) surface, designated as Cit10 112 
and PEG10, respectively, were purchased from Nanocomposix Europe (Prague, Czech Republic). 113 
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), antibiotics and 114 
phosphate buffer saline (PBS, pH 7.4) were purchased from Life Technologies (Carlsbad, CA, 115 
USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Mowoil and DAPI 116 
were obtained from Sigma-Aldrich (St. Louis, MO, USA). 117 
 118 
Physicochemical characterization of AgNPs  119 
The morphology and size of AgNPs were assessed by transmission electron microscopy (TEM) 120 
using a transmission electron microscope Hitachi H9000 NAR (Hitachi High-Technologies 121 
Europe GmbH, Germany) operating at 300 kV. Samples for TEM analysis were prepared by 122 
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evaporating dilute suspensions of AgNPs on a copper grid coated with an amorphous carbon film. 123 
The hydrodynamic diameter and polydispersity index (PdI) were measured by dynamic light 124 
scattering (DLS) and the zeta potential was assessed by electrophoretic mobility, both 125 
measurements using a Zetasizer Nano ZS (Malvern Instruments, UK). Silver quantification 126 
measurements were performed by inductively coupled plasma optical emission spectrometry 127 
(ICP-OES) in an Activa M Radial spectrometer (Horiba Jobin Yvon), employing a charge coupled 128 
device (CCD) array detector, with a wavelength range of 166–847 nm and radial plasma view. 129 
Samples for ICP-OES were prepared by addition of 10 µL AgNPs (1.0 mg/mL) to 990 µL of 130 
either ultrapure water or complete culture medium, incubated for 0, 4, 24 or 48h, then centrifuged 131 
at 40000 rcf for 120 min at 4ºC (in accordance with the manufacturer’s recommendations) to 132 
deposit the nanoparticles and separate the supernatant, which was then digested with acid 133 
(HCl:HNO3 2:1 v/v) before ICP-OES analysis. 134 
 135 
Cell Culture 136 
The HaCaT cell line, a nontumorigenic immortalized human keratinocyte cell line (Boukamp et 137 
al., 1988), was obtained from Cell Lines Services (Eppelheim, Germany). Cells were grown in 138 
complete medium, i.e., Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal 139 
bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 250 140 
µg/mL fungizone at 37 °C in 5% CO2 humidified atmosphere. Cells were observed daily under 141 
an inverted phase-contrast Eclipse TS100 microscope (Nikon, Tokyo, Japan). For each 142 
experiment, cells were allowed to adhere for 24 h and then exposed to Cit10 or PEG10 AgNPs 143 
(dispersed through vortex in cell culture medium). For the assays cells were in passage number 144 
45-50. Depending on the experiment, the silver ion and the coating agent per se, dissolved in 145 
complete medium, were used as controls. The effects were measured after 4, 24 and 48 h.  146 
 147 
Viability assay 148 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 149 
tetrazolium bromide (MTT) assay, measuring intracellular reduction of tetrazolium salts into 150 
purple formazan by viable cells (Twentyman and Luscombe, 1987). Cells were seeded in 96-well 151 
plates at a concentration of 6x104 cells/mL. Fifty microliters of MTT (1 mg/mL) in phosphate 152 
buffered saline (PBS) were then added to each well, and incubated for 4h at 37 °C, 5% CO2. 153 
Medium was then removed and 150 µL of DMSO were added to each well for solubilization of 154 
formazan crystals. The optical density of reduced MTT was measured at 570 nm in a microtiter 155 
plate reader (Synergy HT Multi-Mode, BioTeK, Winooski, VT), and cell viability was calculated 156 
as [(Sample Abs –DMSO Abs) / (Control Abs – DMSO Abs)]*100. Three independent assays 157 
were performed with at least 2 technical replicates each and the results compared with the control 158 
(no exposure).  From our previous MTT results (Bastos et al., 2016), the IC50 for 30 nm citrate 159 
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coated AgNPs (the most cytotoxic) was 40 mg/mL and 37.4 mg/mL at 24 and 48 h respectively. 160 
Therefore, the concentrations of AgNPs corresponding to IC50 and IC20 (40 mg/mL and 10 161 
mg/mL, respectively) were selected for 10 nm AgNPs assays in order to enable comparisons 162 
between sizes. 163 
 164 
Immunofluorescence of p65 subunit of NF-κB in human keratinocytes 165 
After the 4 h treatments with 10 and 40 µg/mL of Cit10 or PEG 10AgNPs, coverslips were washed 166 
with PBS and permeabilized with 0.2% Triton X-100 for 15 min followed by three washes with 167 
PBS. Cells were treated with PBS containing BSA at a concentration of 1 mg/mL as a blocking 168 
agent for 1 hour. Cells were then washed three times with PBS and treated with anti-human NF-169 
κB antibody (p65 subunit, Santa Cruz Biotechnology,Inc. Dallas, Texas USA) diluted 1/200 in 170 
PBS plus 0.5% BSA for 1 hour at room temperature. After three washes with PBS, coverslips 171 
were treated with a second antibody, Alexa fluor 488 anti-rabbit IgG diluted 1:200 in PBS plus 172 
0.5% BSA for 1 hour at room temperature. After three washes with PBS, coverslips were treated 173 
with 0.5μg/ml DAPI in PBS plus 0.5% BSA for 20 seconds, washed in PBS and mounted on glass 174 
microscope slides using Mowoil. Cells were imaged using confocal microscopy. 175 
 176 
Cytokine estimation using cytometric bead array 177 
Cytokine production was assessed using Bioplex kits. Briefly, the supernatants (collected from 178 
cell viability studies, centrifuged and frozen at -80ºC) were used to estimate the release of the 179 
following cytokines from treated cells: interleukin-1 beta (IL-1β), IL-6, tumour necrosis factor-180 
alpha (TNF-α), IL-10 and monocyte chemoattractant protein-1 (MCP-1). Bead array kits were 181 
obtained from Beckton Dickinson (Oxford, UK) and a master mix prepared according to the 182 
manufacturer’s instructions. The master mix was incubated with each of the test supernatants for 183 
1 h, followed by the addition of detection beads and incubated for a further 2 h at room 184 
temperature. The beads were then washed in wash buffer and analysed using a BD FACSArrayTM 185 
flow cytometer which had previously been set up and calibrated using standard beads for each 186 
cytokine under investigation. 187 
 188 
Statistical analysis 189 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of the 190 
3 independent experiments. For MTT assay, the statistical significance between control and 191 
exposed cells was performed by one-way ANOVA, followed by Dunnet and Dunn’s method (as 192 
parametric and non-parametric test, respectively), using Sigma Plot 12.5 software (Systat 193 
Software Inc.). For the other assays, results were compared using two-way ANOVA, followed by 194 
Holm-Sidak test using also Sigma Plot 12.5 software (Systat Software Inc.). The differences were 195 
considered statistically significant for p < 0.05. 196 
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   197 
Results 198 
Physicochemical characterization of AgNPs  199 
A summary of the physico-chemical properties of the NMs is provided in table 1. The spherical 200 
shape and diameter of the AgNPs were verified by transmission electron microscopy, TEM (Fig. 201 
1) and found to agree with the manufacturer information (Table 1). The wavelength of the 202 
maximum absorbance peak in the UV-Vis spectra also matched the expected values. Regarding 203 
the DLS assessment of hydrodynamic diameters (Dh), polydispersity indexes (PdI > 0.3) 204 
indicated large variability in particle size, especially for the Cit10 NPs, hence the Z-average sizes 205 
may lack accuracy. PEG10 NPs showed higher Dh than Cit10, as expected based on the larger 206 
size of PEG compared to citrate. The zeta-potential values confirmed Cit10 AgNPs to have a 207 
negative surface charge (ζ -34 mV), which is expected as citrate is using as a coating to prevent 208 
agglomeration/aggregation through electrostatic repulsions, whereas PEG10 NPs, which are also 209 
designed to stabilize NPs through steric interactions, showed a less negative surface (ζ -14 mV). 210 
We have also assessed the amount of ionic silver (Ag+) released from AgNPs, which was found 211 
to be low in water (< 1%), but significantly increased when the NPs were incubated in culture 212 
medium. Dissolved Ag+ reached 14% in Cit10 suspensions after 4 h and 11 % in PEG10 213 
suspensions after 24 and 48 h, this lower value likely relating to a more efficient protection of 214 
PEG coating against NP surface oxidation. 215 
 216 
Effects on cell growth and viability 217 
HaCaT cells in control conditions (exposed to cell culture medium) showed typical morphology 218 
(Figs. 2a and 3a). When cells were exposed to Cit10 and PEG10 AgNPs for 24 h (2b, 2c, 2d and 219 
2e), their confluence decreased, especially at the highest concentration tested (40 µg/mL). The 220 
decrease in cell confluence was more visible after 48 h (Fig. 3b, 3c, 3d and 3e). Morphologically, 221 
exposed cells (to both Cit10 and PEG10 NPs) showed large precipitates/aggregates of AgNPs in 222 
the medium, and confluence appeared to be, on average, lower for Cit10 exposed cells.    223 
The viability of HaCaT cells was negatively affected by both types of AgNP investigated in this 224 
study (Fig. 4). Relative to controls, the viability of exposed cells was significantly reduced 225 
(p<0.05) upon exposure to Cit10 AgNPs at 10 µg/mL and 40 µg/mL after 4 h, 24 h and 48 h. 226 
Following PEG10 AgNP exposure, the viability of cells following exposure at a concentration of 227 
10 µg/mL was not affected at 4h but a significant reduction in cell viability was observed at 24 228 
and 48 h at this concentration. At a concentration of 40µg/ml PEG10 NPs significantly decreased 229 
cell viability at all time points (4, 24 and 48 h). 230 
 231 
NF-κB activation and inflammatory cytokine release 232 
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Activation of NF-κB in HaCaT cells by AgNPs was evaluated by immunofluorescence; in its 233 
inactive state NF-κB is located in the cytoplasm, and in its active state is localized in the nucleus. 234 
Figure 5 a-c shows a positive control with 240 µM of H2O2 where there is a great intensity of p65 235 
staining in the nucleus. Also, controls (including: cells only (no staining), cells stained with only 236 
the primary antibody and samples stained with the second antibody only) were done to check the 237 
autofluorescence in cells (data not shown). In control cells, most NF-κB staining was localized in 238 
the cell cytoplasm, with occasional occurrence in the nucleus. Regarding AgNP exposed cells, 239 
there was no evidence of NF-κB activation (i.e. no increase in the intensity of staining in the 240 
nucelus) (Fig. 5 e-g). A decrease in p65 staining in the nucleus after exposure to 40 µg/mL PEG10 241 
AgNPs was observed comparing to control cells (Fig. 5h). To confirm the decrease in p65 staining 242 
observed in Fig. 5h, a quantification of the nucleus fluorescence intensity of HaCaT microscopy 243 
images were done using the ImageJ software (Fig. 5i). 244 
The release of cytokines by HaCaT cells treated with AgNPs is shown in Figure 6. 245 
Lipopolysaccharide (LPS) stimulated a significant increase in MCP-1 release at 48h, when 246 
compared to the control. MCP-1 production significantly decreased following exposure of HaCaT 247 
cells to both AgNP types and was most pronounced at a concentration of for 40 µg/mL, compared 248 
to negative and positive controls (p < 0.001). No effects were observed on the other cytokines 249 
studied, IL-1β, IL-6, IL-10 and TNF-α, after exposure to both AgNPs at both times (data not 250 
shown).  251 
 252 
Discussion 253 
Citrate-coated AgNPs are among the most widely used AgNPs in multiple industrial applications 254 
(Tolaymat et al., 2010), while the less used PEG-coated AgNPs have gained increasing attention 255 
over recent years by, for instance, the. biomedical industry due to their high stability and reduced 256 
reactivity (Brandenberger et al., 2010; Ginn et al., 2014; Ryan et al., 2008; Thorley and Tetley, 257 
2013). Therefore, there is need to better understand the influence of coatings of the biological 258 
effects of NPs, and in particular the inflammatory responses. As skin represents one of the major 259 
organs in contact with AgNPs, we compared the viability and inflammatory responses induced 260 
by citrate or PEG-coated AgNPs with a core diameter of 10 nm (Cit10 and PEG10 AgNPs) in 261 
human epidermis keratinocytes (HaCaT cells). 262 
From the cytotoxicity results, Cit10 AgNPs were more toxic than PEG10 NPs. The higher toxicity 263 
of Cit10 AgNPs was particularly relevant for low doses, since a lower concentration (10 µg/mL) 264 
of Cit0 NPs induced a statistically significant decrease in cell viability 4h post exposure, that was 265 
not evident for PEG AgNPs. At higher doses (40 µg/mL) and exposure periods, PEG10 and Cit10 266 
AgNPs reduced viability in similar ways. These data suggest that, for these skin cells, the 267 
influence of coating is more important at low AgNP concentrations, whereas by increasing 268 





2B (bronchial epithelial) cell viability upon exposure to 20 nm citrate-coated AgNPs at 6.25-50 270 
µg/mL after 24 h has been observed previously (Wang et al., 2014). Also, Song et al. (2012) 271 
showed a decrease on cell viability in human liver cell line - HL-7702 after exposure to PEG-272 
coated AgNPs in dose- and time-dependent manner at doses from 6.25μg/mL. Future studies 273 
could assess the sensitivity of different cell types to the AgNPs used in this study. 274 
A complex interplay between environmental and genetic factors control immune system 275 
responses and when a deregulation of immune homeostasis occurs, host defense can be impaired 276 
and at the same time cause excessive and potential harmful inflammatory responses, which could 277 
be responsible for several immune disorders (Bieber, 2008; Morar et al., 2006). The ability of 278 
NPs to elicit pro-inflammatory responses is frequently assessed in in vitro and in vivo studies as 279 
a marker of their toxicity (eg, Schoemaker et al.,  (2002)). Thus, understanding NP-dependent 280 
regulation of cytokine production is essential, since this process conditions shifts from acute to 281 
chronic phases of allergic inflammation (Rossi and Zlotnik, 2000). NF-κB pathways have been 282 
traditionally associated to increases in the production of inflammatory cytokines which could be 283 
implicated in the development of a variety of diseases (Driscoll et al., 1997; Mossman and Churg, 284 
1998). AgNPs did not activate NF-κB in HaCaT cells in this study. In fact, NF-κB may be 285 
inhibited after exposure to the higher concentration (40 µg/mL) of PEG10 AgNPs. It is described 286 
in literature that the inhibition or absence of NF-κB activation induces apoptosis or sensitizes cells 287 
to apoptosis (Schoemaker et al., 2002). 288 
Murray et al (2013) found that a co-exposure of human epidermal keratinocytes (HEK cells) to 289 
superparamagnetic iron oxide (SPION) nanoparticles and UVB induced NF-κB activation and 290 
release of inflammatory mediators such as the cytokines IL-6 and IL-8. Carbon black NPs have 291 
also been demonstrated to induce NF-κB activation in macrophages to stimulate TNFα production 292 
(Brown et al., 2004). However, it has also been recognized that NF-κB signaling has important 293 
functions in the maintenance of physiological immune homeostasis, particularly in epithelial cells 294 
(Wullaert et al., 2011). In a previous work (Bastos et al., 2016), we have demonstrated, by 295 
Annexin-V/PI assay and expression of genes involved in apoptosis, that Cit30 AgNPs induced 296 
preferably necrotic pathways, while cells exposed to PEG30 AgNPs stimulated increases of cells 297 
in earlier phase of apoptosis (therefore a more reversible process) and no necrosis, supporting that 298 
coating conditions how these AgNPs influence the cell apoptosis/necrosis pathways. A major role 299 
of NF-κB pathways involve the regulation of anti-apoptotic genes, by NF-κB directly binding and 300 
inhibiting CASP3, -7 and -9 which seems to be happening in citrate- AgNPs exposed cells 301 
(Schoemaker et al., 2002). Considering that only PEG10 AgNPs inhibit NF-κB, we therefore 302 
hypothesize that this may be involved in the induction of apoptosis by activating CASP3 found 303 
in PEG30-exposed cells versus Cit30-exposed ones. In the future we suggest that NF-κB 304 
activation/inhibition may be used to a greater extent when assessing the hazard of coating and 305 
AgNPs to better understand the mechanisms (i.e. cellular and molecular events) underlying their 306 
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toxicity. On the other hand, Brown et al (2004) showed that ultrafine carbon black particles 307 
(UfCB)-induced nuclear translocation of NF-κB in human monocytes which occurs through ROS-308 
mediated mechanism. Indeed, in our previous study 30 nm citrate- and PEG- AgNPs induced a 309 
significant increase in the production of ROS by HaCaT cells at the highest dose tested (40 310 
μg/mL), compared to control cells. However, the ROS levels were similar for both NP types which 311 
do not explain the NF-κB inhibition by PEG10 AgNPs. Thus, for further studies we also suggest 312 
the quantification of NF-κB activation (e.g. by western blotting) and determination of ROS 313 
production. 314 
Concerning cytokine release, neither Cit10 nor PEG10 AgNPs induced IL-1β, IL-6, IL-10, TNF-315 
α and MCP-1 production by HaCaT cells. Instead, compared to control cells, they decreased 316 
MCP-1 production after 48 h exposure, this reduction being more pronounced at the higher 317 
concentration (40 µg/mL), while the control cells presented an increase of this cytokine as already 318 
described by Takahashi et al (1995) who reported values close to ours for monocytes and 319 
endothelial cells in vitro. The information regarding the influence of AgNPs on the stimulation of 320 
these cytokines from keratinocytes release is scarce, and sometimes contradictory, as different 321 
exposure conditions, concentrations, coating, cell type, NP size and synthesis have been 322 
considered in the literature (Abbott Chalew and Schwab, 2013; Giovanni et al., 2015; Miethling-323 
Graff et al., 2014; Orlowski et al., 2013; Samberg et al., 2010; Suliman Y et al., 2013a; Wong et 324 
al., 2009; Yen et al., 2009). For instance, Orlowski and co-workers (2013) found an increase of 325 
MCP-1 production in murine keratinocytes (murine 291.03C) and by monocytes (RAW 264.7) 326 
after exposure to unmodified AgNPs. Also, human umbilical vein endothelial (HUVEC) cells 327 
showed a significant increase of IL-6, IL-8 and MCP-1 at doses higher than 1 mg/L AgNPs (Shi 328 
et al., 2014). Moreover, confirming the inflammatory potential of AgNPs, several interleukins 329 
and TNF-α were reported to increase upon exposure of HEK cells (Samberg et al., 2010) and 330 
macrophages (Yen et al., 2010) to AgNPs. On the other hand, several authors reported an 331 
undetectable stimulation of cytokines in response to metal NPs, as observed in the present study. 332 
For example, Murray et al (2013) demonstrated that HEK cells exposed to superparamagnetic 333 
iron oxide nanoparticles maintained the IL-1β, IL-10 and TNF-α below detectable levels (while 334 
increasing IL-6); and also that mouse epidermal cells (JB6 P+) maintained INF-γ and IL-12 below 335 
the detectable levels after exposure to the same nanoparticles. Similarly, Samberg et al (2010) did 336 
not find detectable levels of IL-10 in HEK cells exposed to unwashed AgNPs. In mice peritoneal 337 
tissues and in RAW cells, Wong et al (2009) demonstrated that AgNPs have an anti-inflammatory 338 
effect decreasing TNF-α, and INF-γ. Also, Parnsamut and Brimson (2015) found that AgNPs 339 
inhibited TNF-α expression in leukemic cell lines. It is known that cytokines can adsorb onto the 340 
surface of particles, which may compromise their detection (Brown et al., 2010). Thus, it should 341 
not be excluded that AgNPs may induce cytokine production by keratinocytes but that the 342 
cytokines bind to the AgNP surface to prevent their detection. How proteins bind to nanoparticles 343 
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is currently an important topic of debate. For example, Deng et al (2013) showed that human 344 
plasma proteins differently bind to positively and negatively charged polymer-coated gold NPs, 345 
which elicited different biological responses, and that only the negatively charged nanoparticles 346 
induced cytokine release from THP-1 cells. While proteins can bind to different nanoparticles, 347 
the biological outcome may not be the same. Selection of cytokines for assessment in this study 348 
was prioritized based on the outcome of a literature search which identified cytokines that are 349 
commonly produced following exposure of cells to NPs. Future studies could therefore assess a 350 
wider panel of cytokines.  351 
In summary, our study demonstrated that while citrate- and PEG-coated AgNPs decreased the 352 
viability of HaCaT cells. Citrate coated AgNPs were more cytotoxic than PEG coated NPs, 353 
particularly at low concentrations and shorter incubation times. At higher AgNPs concentration, 354 
the influence of coating became less relevant. Also, we demonstrated that, independent of the 355 
coating, AgNPs did not induce cytokine production, and decreased MCP-1 release. Finally, 356 
PEG10 AgNPs at high concentrations inactivated the transcription factor NF-κB, and putative 357 
correlation with anti-inflammatory and anti-apoptotic homeostasis should be further explored.  358 
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 535 
Fig. 1 Transmission electron microscopy (TEM) images of Cit10 and PEG10 AgNPs used in this 536 
work 537 
 538 
Fig. 2 Light microscopy images (100X) of HaCaT cells exposed to 10 nm citrate- AgNPs or PEG- 539 
AgNPs (Cit10 or PEG10) for 24 h. a) 0 (control); b) Cit10, 10 µg/mL; c) Cit10, 40 µg/mL; d) 540 
PEG10, 10 µg/mL; and e) PEG10, 40 µg/mL. Bar corresponds to 100 µm 541 
 542 
Fig. 3 Light microscopy images (100X) of HaCaT cells exposed to 10 nm citrate- AgNPs or PEG- 543 
AgNPs (Cit10 or PEG10) for 48 h. a) 0 (control); b) Cit10, 10 µg/mL; c) Cit10, 40 µg/mL; d) 544 
PEG10, 10 µg/mL; and e) PEG10, 40 µg/mL. Bar corresponds to 100 µm 545 
 546 
Fig. 4 Relative cell viability (%) of HaCaT cells  after exposure to 10 and 40 µg/mL of 10 nm 547 
citrate- AgNPs or PEG- AgNPs (Cit10 or PEG10), measured by MTT assay, at 4, 24 and 48 h 548 
post exposure. Data expressed as mean and standard deviation (n = 3). * indicate significant 549 
differences between control at p < 0.05 550 
 551 
Fig. 5 Microscopy images of HaCaT cells. a) - c) are fluorescence microscopy images (400X) of 552 
immunofluorescence of HaCaT cells treated with anti NF-kB p65 antibody after stimulation with 553 
240 µM H2O2 for 10 min prior fixation: a) p65 subunit of NF-kB (alexa fluor 488 anti-rabbit IgG); 554 
17 
 
b) DAPI staining the nucleus; c) Overlap of a and b images. d) - h) are confocal microscopy 555 
images of immunofluorescence of p65 subunits of NF-kB in human HaCaT keratinocytes exposed 556 
to AgNPs for 4 h: d) 0 (control); e) 10 µg/mL of Cit10; f) 40 µg/mL of Cit10; g) 10 µg/mL of 557 
PEG10; h) 40 µg/mL of PEG10. Bar corresponds to 100 µm. i) is the quantification of the nucleus 558 
fluorescence intensity of HaCaT microscopy images presented in Fig.4h using the ImageJ 559 
software. Data expressed the mean and standard deviation. ** indicate significant differences 560 
between control at p < 0.01 561 
 562 
Fig. 6 Cytokine release by HaCaT cells after 24 and 48h exposure to 10 nm citrate- or PEG- 563 
AgNPs (Cit10 or PEG10). Control + is a positive control by adding LPS to cells. Data represent 564 
the mean ± standard deviation (n = 3) of the concentration (pg /ml) of MCP-1 cytokine released 565 
from the cells after NPs treatment 566 
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